Literature DB >> 2190946

The inheritance of MS susceptibility.

D Lord1, A G O'Farrell, H Staunton, E Keelan.   

Abstract

The object of this study was to determine, if possible, the mode of inheritance of the susceptibility to multiple sclerosis (MS). It was known that no single-gene model could fit the observations, so oligogenic models (models involving a small number of genes) were sought. Oligogenic hypotheses were tested against the available population data for MS until a reasonable level of agreement was found. The best-fitting simple hypothesis was this: MS occurs only in people who are homozygous for a recessive gene and carry a dominant X gene, and then only with reduced penetrance. The dangerous allele m- at the autosomal locus appears to be fairly uniformly distributed across England, Ireland and Canada, occurring in 10-30% of the gene pool. There are large variations in the frequency of the allele s- at the X-locus, ranging from 10% up to 72% of the gene pool. The penetrance varies significantly with geographical location, but nowhere approaches unity, so that the environmental factors are of great importance. The hypothesis explains the broad features of the population pattern of the occurrence of MS and it gives an outstanding fit to the best available data on MS in relatives. The result may assist attempts to map the genetic data on MS, opens the way for a reassessment of the attempts to identify the environmental factors, and it makes possible the completion of nonempirical risk tables for various countries. Similar techniques may be applied to other disorders with a genetic component in their aetiology.

Entities:  

Mesh:

Year:  1990        PMID: 2190946     DOI: 10.1007/bf02938002

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  27 in total

1.  Polymorphisms and multiple sclerosis in Orkney.

Authors:  D F Roberts; S S Papiha; D C Poskanzer
Journal:  J Epidemiol Community Health       Date:  1979-12       Impact factor: 3.710

2.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

3.  Familial and conjugal multiple sclerosis.

Authors:  K SCHAPIRA; D C POSKANZER; H MILLER
Journal:  Brain       Date:  1963-06       Impact factor: 13.501

4.  The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients.

Authors:  A D Sadovnick; P A Baird
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

5.  The frequency of multiple sclerosis in Western Australia.

Authors:  M G McCall; J M Sutherland; E D Acheson
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

6.  Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution.

Authors:  J F Kurtzke; G W Beebe; J E Norman
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

7.  Genetic analysis of multiple sclerosis in Orkney.

Authors:  D F Roberts; M J Roberts; D C Poskanzer
Journal:  J Epidemiol Community Health       Date:  1979-12       Impact factor: 3.710

8.  The genetic contribution to multiple sclerosis. Evidence from North-East England.

Authors:  D F Roberts; D Bates
Journal:  J Neurol Sci       Date:  1982-05       Impact factor: 3.181

9.  Multiple sclerosis in the Republic of Ireland.

Authors:  R Brady; G Dean; S Secerbegovic; A M Secerbegovic
Journal:  Ir Med J       Date:  1977-11-18

10.  Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies.

Authors:  M Elian; G Dean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.